share_log

Forecasting The Future: 7 Analyst Projections For Novo Nordisk

Forecasting The Future: 7 Analyst Projections For Novo Nordisk

預測未來:7位分析師對諾和諾德的預測
Benzinga ·  04:00
In the latest quarter, 7 analysts provided ratings for Novo Nordisk (NYSE:NVO), showcasing a mix of bullish and bearish perspectives.
在最新的季度中,有7位分析師爲Novo Nordisk(紐交所:NVO)提供了評級,展示了看好和看淡的觀點混合。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中,您將找到他們最近的評級摘要,揭示了過去30天內情緒的變化,並將它們與前幾個月進行比較。
Analysts have set 12-month price targets for Novo Nordisk, revealing an average target of $159.43, a high estimate of $160.00, and a low estimate of $156.00. A decline of 0.36% from the prior average price target is evident in the current average.
分析師爲諾和諾德設定了12個月的價格目標,顯示出平均目標爲159.43美元,最高估值爲160.00美元,最低估值爲156.00美元。當前平均價格較上一個平均價格目標下跌了0.36%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探討分析師評級:分析師評級的深度探討
The analysis of recent analyst actions...
最近分析師行...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論